Purdue Pharma’s opioid overdose drug gets US regulator’s nod
US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
US drugmaker Purdue Pharma’s injection to treat opioid overdose in adults and patients 12 years or older, got the country’s drug regulator’s approval.
HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.